Highest yielding salt tolerant wheat developed

Washington, Apr 24 (ANI): A group of researchers has developed a salt tolerant durum wheat that yields 25 per cent more grain than the parent variety in saline soils.

The breakthrough will enable wheat farmers to achieve higher yields of durum wheat in saline soils. Although durum wheat is less salt tolerant than bread wheat it attracts a premium price because of its superior pasta making qualities.

Recent field trials in northern New South Wales proved that durum wheat varieties containing new salt tolerant genes outperformed the other varieties in saline soils.

“By planting the new salt tolerant durum wheats in different levels of salinity and comparing their yield with other durum wheats, we’ve demonstrated an impressive 25 per cent yield advantage under saline soil conditions,” says CSIRO scientist, Dr Richard James.

The CSIRO Plant Industry research team responsible for the breakthrough recently isolated two salt tolerance genes (Nax1 and Nax2) derived from the old wheat relative Triticum monococcum.

“Both genes work by excluding sodium, which is potentially toxic, from the leaves by limiting its passage from the roots to the shoots,” says the leader of the project, Dr Rana Munns.

Through traditional, non-GM breeding methods aided by molecular markers the team was able to introduce the salt exclusion genes into durum wheat lines.

Salinity, a major environmental issue affecting much of Australia’s prime wheat-growing areas, often prevents farmers from growing durum wheat. (ANI)

New stem cell therapy to help women regrow breasts after cancer surgery

Melbourne, Apr 17 (ANI): A new stem cell therapy developed by Melbourne scientists could help women regrow their breasts after cancer surgery.

Doctors at the Bernard O”Brien Institute of Microsurgery will start the trial for new technique called Neopec in coming months.

The new method uses a woman”s own regenerative capacity to grow new fat tissue in her breasts.

The world-first trial will involve five women who have had tissue removed during surgery to remove cancer, and the first results could be reported by the end of the year.

Neopec involves implanting a breast-shaped biodegradable chamber into the chest before surgeons redirect blood vessels into the chamber with the patient”s own fat cells.

A gel is inserted to help the cells multiply over four to six months, and the chamber dissolves when the new breast is fully formed.

According to lead researcher Wayne Morrison, after successfully trialling the procedure on pigs, he was about 50 per cent sure it would work in humans.

””If it works it will be great, but we can”t be sure that it will yet,” the Age quoted Professor Morrison as saying.

The new chief executive of the operation, Dr Peter Mountford, said if the trial was successful, by 2013 he would offer the procedure to women in Australia, Europe and south-east Asia who had had a partial mastectomy, defects of previous reconstructions or congenital deformities.

And the cosmetic market would come next.

””By 2015, Neopec will be able to provide full breast reconstruction and by 2020, in conjunction with a global partner, it will provide a natural alternative to women within the burgeoning breast augmentation market,”” said Mountford.

He said the procedure would be marketed at a premium price to implants currently on the market because it would be safer and more natural than the insertion of foreign materials.

Once perfected, it would also involve only one procedure and a shorter hospital stay than existing implantation methods. (ANI)

Woody Allen asked to prove he still commands $10M endorsement fee

London, Apr 10 (ANI): American Apparel bosses have asked filmmaker Woody Allen to prove that he can still command a price of 10 million dollars for appearing in commercials.

The ‘Match Point’ director had filed a lawsuit against the clothing giants last year, and claimed that they used his likeness on billboards without his consent.

In the adverts across New York and Los Angeles, he was depicted dressed as a rabbi.

Allen claimed that his price for appearing in a commercial usually started at 10 million dollars.

But bosses at the company are now demanding the legendary filmmaker to prove it in court.

In papers filed at Manhattan Federal Court, lawyers for the clothing company’s boss Dov Charney have asked for records to show that Allen can still command a “premium price” for his endorsement of products.

“We believe that Mr Allen’s popularity has decreased significantly, especially in light of the scandals he’s been associated with,” the Daily Express quoted lawyer Stuart Slotnick as telling New York Post,

He added: “We believe that he greatly overvalues the worth of his endorsement – if he can get one.” (ANI)

Jacko’s comeback tour in tickets row

Washington, Mar 14 (ANI): Promoters of Michael Jackson’s comeback gigs are threatening to sue a ticket agency for allegedly selling prized seats to another company.

AEG Live teamed up with Viagogo to market premium price packages for the highly anticipated shows at London’s O2 Arena.

However, the ticket agency has been accused of breaking an agreement not to sell tickets to touts or other brokers – and they are now planning to seek an injunction to protect the deal.

“My lawyers are going into court to seek an injunction,” Contactmusic quoted Randy Phillips, chief executive of AEG Live as saying.

“They (Viagogo staff) sent out an email to touts and brokers offering tickets for sale. We are going to come down very hard on them,” he added.

Jackson will be performing 50 shows at the O2 running into next year (2010) – a residency that will generate 100 million dollars in ticket sales alone. (ANI)